(6R,8R,9S,10R,13S,14S)-10,13-dimethyl-6-(5-phenylpentyl)-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-3H-cyclopenta[a]phenanthrene-3,17(2H)-dione

ID: ALA5287546

Max Phase: Preclinical

Molecular Formula: C30H40O2

Molecular Weight: 432.65

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@]12CCC(=O)C=C1[C@H](CCCCCc1ccccc1)C[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12

Standard InChI:  InChI=1S/C30H40O2/c1-29-17-15-23(31)20-27(29)22(12-8-4-7-11-21-9-5-3-6-10-21)19-24-25-13-14-28(32)30(25,2)18-16-26(24)29/h3,5-6,9-10,20,22,24-26H,4,7-8,11-19H2,1-2H3/t22-,24+,25+,26+,29-,30+/m1/s1

Standard InChI Key:  GCSSARXWDGCYBP-INIXEJBKSA-N

Molfile:  

 
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
    1.1928    4.0144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0989    3.1948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3854    3.6176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3412    3.2127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3412    2.3824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0627    1.9802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2272    2.5829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7709    2.4004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4991    1.9943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4991    1.1693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2192    0.7632    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7910    0.7491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0627    1.1513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3575    0.7325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3575   -0.0940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3583   -0.5072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3583   -1.3338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0741   -1.7471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0741   -2.5736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7899   -2.9869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7899   -3.8171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5078   -4.2260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2192   -3.8134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2192   -2.9865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5059   -2.5738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3706    1.1386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3706    1.9637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9936    1.2797    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.0989    2.3698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8733    2.1038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3653    2.7706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8874    3.4435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1533    4.2260    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4510    1.4657    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2011    2.8955    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  8  6  1  0
  9  8  1  0
 10  9  1  0
 11 10  2  0
 10 12  1  0
 12 13  2  0
 13  6  1  0
 14 13  1  0
 14 15  1  1
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 20  2  0
 26 14  1  0
 26 27  1  0
 27  5  1  0
 27 28  1  1
 29 27  1  0
  2 29  1  0
 30 29  1  0
 31 30  1  0
 32 31  1  0
 32  2  1  0
 33 32  2  0
 29 34  1  6
  5 35  1  6
M  END

Alternative Forms

  1. Parent:

    ALA5287546

    ---

Associated Targets(Human)

CYP19A1 Tclin Cytochrome P450 19A1 (6099 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 432.65Molecular Weight (Monoisotopic): 432.3028AlogP: 7.12#Rotatable Bonds: 6
Polar Surface Area: 34.14Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 7.57CX LogD: 7.57
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.45Np Likeness Score: 1.69

References

1. Adhikari N, Baidya SK, Jha T..  (2020)  Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors.,  208  [PMID:33017749] [10.1016/j.ejmech.2020.112845]

Source